Transference of the biotechnological investigation orientated to the managerial profitability and mobilization of flows of business

Biopharmac

The BIOPHARMAC Project, which was co-financed by the European Transnational Cooperation Program MAC 2007-2013 and FEDER funds, had the following partners: Canarian Foundation of the Canary Institute of Cancer Research (FICIC, Tenerife - Spain), Madeira University (Portugal), Universidade dos Açores (Portugal), University of La Laguna (Tenerife - Spain), and Cabildo Insular de Tenerife as Project Leader.


The general goal of the BIOPHARMAC project (project that gives continuity to the BIOPOLIS Interreg IIIB project), was to strengthen the biotechnology and pharmaceutical industry based on Macaronesian knowledge and biodiversity.


One of the main tasks of the project was the development of transregional and transnational cooperation networks in the field of Biotechnology and Pharmacology.

Its purpose was to promote and facilitate the scientific and technology transfer from universities and other R+D+I centres to companies, strengthening the research, technology and innovation system of the participating regions at a regional and international level and, thus, contribute to improve the competitiveness of this sector.


The objectives of the BIOPHARMAC Project during the years 2009 and 2012 were to promote the R&D of excellence in the biotechnology and pharmaceutical sector of Macaronesia, transfer knowledge and technology from the areas of Biotechnology and Pharmacy to the business sector and promote the creation of new Technology-Based Companies in Biotechnology and Pharmacy.


In order to perpetuate such objectives and ensure the sustainability of the results achieved, in 2011 the Institutional Network of Transnational Cooperation between Universities, Research and Development Centers, Investors and Biotechnological and Pharmaceutical Industries of Macaronesia was set up.